Author Archives: admin

In a recent study published in the journal Open Forum Infectious Diseases, researchers investigated COVID-19’s impact on severe maternal morbidity (SMM), potentially lethal complications that occur during the time of childbirth. They used declassified data from over 93,600 deliveries between March 2020 and July 2021 and found that risks, particularly those of adult respiratory distress […]

SAN DIEGO — In the real world, outcomes for patients with multiple myeloma who received standard regimens were dramatically worse than those reported in clinical trials, a new study found.  The analysis, which included nearly 4000 patients with multiple myeloma, revealed that patients in a real-world setting demonstrated worse progression-free and overall survival on six […]

SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical practice must change accordingly, to keep up with modern treatment options and to make the most of new drugs that can target key pathophysiological pathways. In line […]

Roughly 10% of fecal immunochemical tests (FIT) used for colorectal cancer (CRC) screening by a safety-net health system contained unsatisfactory samples that could not be processed. And fewer than half of patients with unacceptable FIT samples completed a follow-up test within 15 months, a large retrospective study finds. “The high prevalence of unsatisfactory FIT in […]

UKHSA is strongly encouraging eligible people from ethnic minority groups, particularly people from the Pakistani and black Caribbean ethnic groups and individuals living in more deprived areas, to book their flu and COVID-19 vaccines. This will protect them and their families against the heightened risks of these infections during winter. Data from UKHSA’s report on […]

A new risk model for nonalcoholic fatty liver disease (NAFLD) could offer a simpler and more accurate way of predicting advanced fibrosis in first-degree relatives, according to investigators. By leveraging basic clinical factors instead of more advanced diagnostic findings, the NAFLD Familial Risk Score is more scalable than existing strategies for identifying advanced fibrosis, reported […]

In a recent study published in Pharmaceuticals Journal, researchers performed several analytic experiments on the optimized Psychotria malayana Jack (P. malayana) leaf extract (OE) to evaluate its anti-diabetic, anti-inflammatory, and antioxidant properties.  Specifically, they evaluated its α-glucosidase inhibition (AGI) potential, inflammation inhibitory activity using the soybean lipoxygenase inhibitory (SLOXI) test, antioxidant activity using the Ferric Reducing Antioxidant Power (FRAP) and […]

Patients receiving semaglutide for weight loss show a significantly higher rate of continuing the medication at 1 year compared with less effective anti-obesity drugs. However, even among those patients, continuation declines to fewer than half of patients. “We now have effective US Food and Drug Administration-approved anti-obesity medications; [however], this study shows that in a […]

In a recent study published in the journal NPJ Digital Medicine, researchers reviewed current guidelines on the ethical implementation of Artificial Intelligence (AI) in military and healthcare applications. Their discussions focus on ‘generative AI,’ a novel technology aimed at efficiently generating information, and attempts to overcome currently prevalent limitations on the ethical use of the […]

(Reuters) – Eli Lilly’s recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost customers whose health insurance does not cover the drug $550 a month, or half the list price, the company said on Tuesday. Zepbound is the latest entrant to the fast-growing market for weight-loss drugs, which is expected […]